AIDS dementia complex

Neurologic Clinics

Volumn 17, Issue 4, 1999, Pages 861-881

  Brew, B J ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMPRENAVIR; ANTIRETROVIRUS AGENT; EFAVIRENZ; HYDROXYUREA; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; PENTOXIFYLLINE; RITONAVIR; SAQUINAVIR; ZIDOVUDINE;

AIDS RELATED COMPLEX; CLINICAL FEATURE; DEMENTIA; DIAGNOSTIC APPROACH ROUTE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; NEUROIMMUNOLOGY; NEUROPATHOLOGY; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW;

EID: 0032703399     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8619(05)70170-5     Document Type: Article

References (116)

1. H. Bacellar A. Munoz E.N. Miller Temporal trends in the incidence of HIV-1 related neurologic diseases: Multicentre AIDS cohort study 1985–1992 Neurology 44 1994 1892 1900
2. O. Bagasra E. Lavi L. Bobroski Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: Identification by the combination of in situ polymerase chain reaction and immunochemistry AIDS 10 1996 573 586
3. T. Baldeweg J. Catalan E. Lovett Long term zidovudine reduces neurocognitive deficits in HIV-1 infection AIDS 9 1995 589 596
4. T. Baldeweg J. Catalan B.G. Gazzard Risk of HIV dementia and opportunistic brain disease in AIDS and zidovudine therapy J Neurol Neurosurg Psychiatry 65 1998 34 41
5. T. Baldeweg J. Catalan B.G. Gazzard Kaposi's sarcoma and protection from HIV dementia Science 280 1998 362
6. P.B. Barker R.R. Lee J.C. McArthur AIDS dementia complex: Evaluation with proton MR spectroscopic imaging Radiology 195 1995 58 54
7. C.F. Barroga R. Ellis J. Nelson HIV-1 neurocognitive disorders and chemokine receptors AIDS 11 1997 1652 1651
8. G.L. Beckloff H.J. Lerner D. Frost Hydroxyurea in biologic fluids: Dose concentration relationship Cancer Chemotherapy Reports 34 1963 57 58
9. J.E. Bell A. Busutil J.W. Ironside Human immunodeficiency virus and the brain: Investigation of virus load and neuropathologic changes in pre-AIDS subjects J Infect Dis 168 1993 818 824
10. B.J. Brew Central and peripheral nervous system abnormalities in HIV-1 infection White D.A. Gold J.W.M. Medical Management of AIDS Patients. Medical Clinics of North America vol 76 1992 WB Saunders Philadelphia 63 81 1
11. B.J. Brew AIDS dementia complex and its prevention Antiviral Therapy 2 suppl 3 1997 69 73
12. B.J. Brew Neurological efficacy of stavudine and lamivudine Lancet 352 1998 402
13. B.J. Brew R.B. Bhalla M. Fleischer Cerebrospinal fluid Beta-2 microglobulin in patients infected with human immunodeficiency virus type 1 Neurology 39 1989 834 830
14. 2 microglobulin in patients with AIDS dementia complex: An expanded series including response to zidovudine treatment AIDS 6 1992 461 465
15. B.J. Brew R.V. Bhalla M. Schwartz Cerebrospinal fluid concentrations of neopterin in human immunodeficiency virus infection Ann Neurol 28 1990 556 560
16. B.J. Brew S.J. Brown J. Catalan Safety and efficacy of Abacavir (ABC, 1592) AIDS Dementia Complex (Study CNAB 3001) 12th World AIDS Conference Geneva June 28–July 3, 1998
17. 2 microglobulin and neopterin predict the development of AIDS dementia complex J Infect Dis 174 1996 294 298
18. B.J. Brew L. Evans C. Byrne The relationship between AIDS dementia complex and the presence of macrophage tropic and non syncytium inducing isolates of human immunodeficiency virus type 1 in the cerebrospinal fluid J Neurovirol 2 1996 152 157
19. B.J. Brew J. Miller Human immunodeficiency virus type 1 related transient neurologic deficits Am J Med 101 1996 257 261
20. B.J. Brew M. Paul A. Khan Cerebrospinal fluid HIV-1 p24 antigen and culture: Sensitivity and specificity for AIDS dementia complex J Neurol Neurosurg Psychiatry 57 1994 784 789
21. B.J. Brew L. Pemberton P. Cunningham Levels of HIV-1 RNA correlate with AIDS dementia J Infect Dis 175 1997 963 966
22. B.J. Brew P. Portegies Antiretroviral drugs within the CSF The Pathogenesis and Treatment of HIV CNS Infection 1997 International Medical Press London 14 15
23. B.J. Brew M. Rosenblum K. Cronin The AIDS dementia complex and human immunodeficiency virus type 1 brain infection: Clinical-virological correlations Ann Neurol 38 1995 563 570
24. B.J. Brew S.L. Wesselingh M. Gonzales How HIV leads to neurological disease Med J Aust 164 1996 233 234
25. K. Brinkman J.M. Hadewych D. Burger Adverse effects of reverse transcriptase inhibitors: Mitochondrial toxicity as a common pathway AIDS 12 1998 1735 1744
26. H. Budka C.A. Wey P. Kleihues HIV-associated disease of the nervous system: Review of nomenclature and proposal for neuropathology based terminology Brain Pathol 1 1991 143 152
27. K.M. Butler R.N. Husson F.M. Balis Dideoxyinosine in children with symptomatic human immunodeficiency virus infection N Engl J Med 324 1991 137 144
28. F. Chiodi J. Albert E. Olausson Isolation frequency of human immunodeficiency virus from cerebrospinal fluid and blood of patients with varying severity of HIV infection AIDS Res Hum Retroviruses 4 1988 351 358
29. Cunningham P, Smith D, Satchell C, et al: In vivo comparison of reverse transcriptase inhibitor resistance patterns in paired cerebrospinal fluid and blood of HIV-1 infected patients with a novel LiPA. 9th Annual Conference Australasian Society for HIV Medicine, Adelaide, November 13–16, 1997
30. J. Currie E. Benson B. Ramsden Eye movement abnormalities as a predictor of the acquired immunodeficiency syndrome dementia complex Arch Neurol 45 1988 949 953
31. Dal Pan G.J. J.D. Glass J.C. McArthur Clinicopathological correlations of HIV-1 associated vacuolar myelopathy: An autopsy based case control study Neurology 44 1994 2159 2164
32. D.W. Dickson S.C. Lee Microglia in HIV-related neuropathology: An update J NeuroAIDS 1 1996 57 84
33. G.J. Dore P.K. Correll Y. Li Changes to AIDS dementia complex in the era of highly active antiretroviral therapy AIDS 13 1999 1249 1253
34. G.J. Dore A. Grulich M.G. Law Kaposi's sarcoma and protection from AIDS dementia complex AIDS 12 1998 2354 2355
35. G.J. Dore J. Hoy S.A. Mallal Trends in incidence of AIDS illnesses in Australia from 1983 to 1994: The Australian AIDS Cohort J Acquir Immune Defic Syndr 16 1997 39 43
36. G.J. Dore M. Law B.J. Brew Prospective analysis of seizures occurring in human immunodeficiency virus type 1 infection J NeuroAIDS 1 1996 59 70
37. N. Dunbar B.J. Brew Neuropsychological dysfunction in HIV infection: A review J NeuroAIDS 1 1996 73 102
38. N. Dunbar L. Pemberton M. Perdices Clinical markers of the presence of dementia and neuropsychological impairment in HIV infection J NeuroAIDS 1 1996 31 48
39. R.J. Ellis K. Hsia S.A. Spector Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels in neurocognitively impaired individuals with acquired immunodeficiency syndrome Ann Neurol 42 1997 679 688
40. R.H. Enting R.M.W. Hoetelmans J.M.A. Lange Antiretroviral drugs and the central nervous system AIDS 12 1998 1941 1955
41. M.M. Esiri C.S. Morris Cellular basis of HIV infection of the CNS and the AIDS dementia complex: Oligodendrocyte J NeuroAIDS 1 1996 133 160
42. I.P. Everall Neuropsychiatric aspects of HIV infection J Neurol Neurosurg Psychiatry 58 1995 399 402
43. I.P. Everall P.J. Luthert P.L. Lantos Neuronal loss in the frontal cortex in HIV infection Lancet 337 1991 1119 1121
44. Ferrando S. Van Gorp W. M. McElhiney Highly active antiretroviral treatment in HIV infection: Benefits for neuropsychological function AIDS 12 1998 F65 F70
45. R.A.M. Fouchier M. Brouwer N.A. Kootstra HIV-1 macrophage tropism is determined at multiple levels of the viral replication cycle J Clin Invest 94 1994 1806 1814
46. N. Foudraine R. Hoetelmans J.M.A. Lange Cerebrospinalfluid HIV-RNA and drug concentrations during treatment with lamivudine (3TC) in combination with zidovudine (AZT) or stavudine (d4T) Lancet 351 1998 1547 1551
47. P. Gallo K. Frei C. Rordorf Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: An evaluation of cytokines in cerebrospinal fluid J Neuroimmunol 23 1989 109 116
48. M. Gisslen G. Norkrans B. Svennerholm The effect on human immunodeficiency virus type 1 RNA levels in the cerebrospinal fluid after initiation of zidovudine or didanosine J Infect Dis 175 1997 434 437
49. J.D. Glass H. Fedor S.L. Wesselingh Immunocytochemical quantitation of HIV in the brain: Correlations with HIV-associated dementia Ann Neurol 38 1995 755 762
50. J.D. Glass S.L. Wesselingh O.A. Selnes Clinical-neuropathologic correlation in HIV-associated dementia Neurology 43 1993 2230 2237
51. D.S. Goodin M.S. Aminoff D.N. Chernoff Long latency event-related potentials in patients infected with human immunodeficiency virus Ann Neurol 27 1990 414 419
52. I. Grant J.H. Atkinson J.R. Hesselink Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus infections. Studies with neuropsychologic testing and magnetic resonance imaging Ann Intern Med 107 1987 828 836
53. L.M. Grimaldi C.V. Martino D.M. Franciotta Elevated alpha tumour necrosis factor levels in spinal fluid from HIV-1 infected patients with central nervous system involvement Ann Neurol 29 1991 21 25
54. R.K. Heaton T.D. Marcotte R.J. Ellis Neuropsychological profile and prognostic significance of minor cognitive/motor disorder J Neurovirol 2 1996 39
55. M.P. Heyes B. Brew A. Martin Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome Adv Exp Med Biol 294 1991 687 690
56. D.M. Holtzman D.A. Kaku Y.T. So New onset seizures associated with human immunodeficiency virus infection: Causation and clinical features in 100 cases Am J Med 87 1989 173 177
57. R.S. Janssen A.J. Saykin J.E. Kaplan Neurological complications of human immunodeficiency infection in patients with lymphadenopathy syndrome Ann Neurol 23 1988 49 55
58. J.G. Jarvik J.R. Hesselink C. Kennedy Acquired immunodeficiency syndrome: Magnetic resonance patterns of brain involvement with pathologic correlation Arch Neurol 45 1988 731 736
59. S.S. Kamin C.K. Petito Vacuolar myelopathy in immunocompromised non AIDS patients J Neuropathol Exp Neurol 47 1988 385
60. J.N. Keating C. Trimblek F. Mulcahy Evidence of brain methyltransferase inhibition and early brain involvement in HIV positive patients Lancet 337 1991 935 939
61. W. Kelder J.C. McArthur T. Nance-Sproson β-chemokines, MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia Ann Neurol 44 1998 831 835
62. S. Ketzler S. Weiss H. Haugh Loss of neurons in the frontal cortex in AIDS brains Acta Neuropathologica 80 1990 92 94
63. 12 metabolism in human immunodeficiency virus infection Arch Neurol 48 1991 312 314
64. I.J. Koralnik A. Beaumanos R. Hausler A controlled study of of neurologic abnormalities in men with asymptomatic immunodeficiency virus infection N Engl J Med 323 1990 864 870
65. K. Liestoel A.K. Goplen O. Dunlop Kaposi's sarcoma and protection from HIV dementia Science 280 1998 361 362
66. S.A. Lipton Memantine prevents HIV coat protein-induced neuronal injury in vitro Neurology 42 1992 1403 1405
67. S.A. Lipton H.E. Gendelman Dementia associated with the acquired immunodeficiency syndrome N Engl J Med 332 1995 934 940
68. D.W. Marshall R.L. Brey W.T. Cahill Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection Arch Neurol 45 1988 954 958
69. J.C. Masdeu A. Yudd Van Heertum R.L. Single photon emission computed tomography in human immunodeficiency virus encephalopathy: A preliminary report J Nucl Med 32 1991 1471 1475
70. J.C. McArthur B.A. Cohen O.A. Selner Low prevalence of neurological and neuropsychological abnormalities in otherwise healthy HIV-1 infected individuals: Results from the multicentre AIDS cohort study Ann Neurol 26 1989 601 611
71. J.C. McArthur B.A. Cohen O.A. Selnes Low prevalence of neurological and neuropsychological abnormalities in otherwise healthy HIV-1 individuals: Results from the multicenter AIDS cohort study Ann Neurol 26 1989 601 611
72. J.C. McArthur D.R. Hoover H. Bacellar Dementia in AIDS patients: Incidence and risk factors Neurology 43 1993 2245 2252
73. J.C. McArthur D.R. McClernon M.F. Cronin Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain Ann Neurol 42 1997 689 698
74. P.T. Merrill P.T. Paige R.A. Abrams Ocular motor abnormalities in human immunodeficiency virus infection Ann Neurol 30 1991 130 138
75. D.J. Meyerhoff S. DrRerNat M.D. Mackay Reducted brain N-acetylaspartate suggest neuronal loss in cognitively impaired human immunodeficiency virus-seropositive individuals: In vivo H magnetic resonance spectroscopic imaging Neurology 43 1993 509 515
76. A.V. Moses S.G. Stenglein J.A. Nelson HIV infection of the brain microvasculature and its contribution to the AIDS dementia complex J NeuroAIDS 1 1996 85 100
77. Navia B. Cho E.-S. C.K. Petito The AIDS dementia complex: II. Neuropathology Ann Neurol 19 1986 525 535
78. B. Navia B.D. Jordan R.W. Price The AIDS dementia complex: I. Clinical features Ann Neurol 19 1986 517 524
79. G.J. Nuovo F. Gallery P. MacConnell In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-RNA in the central nervous system Am J Pathol 144 1994 659 666
80. M.R. Nuwer E.N. Miller B.R. Visscher Asymptomatic HIV infection does not cause EEG abnormalities: Results from the multicentre AIDS cohort study (MACS) Neurology 42 1992 1214 1219
81. A. Parisi G. DiPerri M. Strosselli Usefulness of computerised electroencephalography in diagnosing, staging and monitoring AIDS dementia complex AIDS 3 1989 209 213
82. H.K. Patton E.N. Benveniste D.J. Benos Astrocytes and the AIDS dementia complex J NeuroAIDS 1 1996 111 132
83. C.K. Petito Ependyma and choroid plexus J NeuroAIDS 1 1996 101 110
84. C.K. Petito B.A. Navia Cho E.-S. Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with acquired immunodeficiency syndrome (AIDS) N Engl J Med 312 1985 874 879
85. P. Portegies R.H. Enting J. DeGan Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam, The Netherlands AIDS 7 1993 669 675
86. P. Portegies L.G. Epstein S.T.A. Hung Human Immunodeficiency Virus Type 1 antigen in cerebrospinal fluid correlation with clinical neurologic status Arch Neurol 46 1989 261 264
87. P. Portegies R.H. Enting de Jong M.D. AIDS dementia complex and didanosine (ddI) Lancet 344 1994 759
88. C. Power P.A. Kong T.O. Crawford Cerebral white matter changes in acquired immunodeficiency syndrome dementia: Alterations of the blood brain barrier Ann Neurol 34 1993 339 359
89. C. Power J.C. McArthur R.T. Johnson Demented and non-demented patients with AIDS differ in brain derived human immunodeficiency virus type 1 envelope sequences J Virol 68 1994 4643 4649
90. R.W. Price The cellular basis of central nervous system HIV-1 infection and the AIDS dementia complex: Introduction J NeuroAIDS 1 1996 1 30
91. R.W. Price B.J. Brew The AIDS dementia complex J Infect Dis 158 1988 1079 1083
92. Report of a Working Group of the American Academy of Neurology AIDS Task Force: Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus type 1 (HIV-1) infection Neurology 41 1991 778 785
93. L. Resnick J.R. Berger P. Shapshak Early penetration of the blood-brain barrier by HIV Neurology 38 1988 9 14
94. M. Rosenblum A.C. Scheck K. Cronin Dissociation of AIDS related vacuolar myelopathy and productive HIV-1 infection of the spinal cord Neurology 39 1989 892 896
95. D. Rottenberg J. Moeller S. Strother The metabolic pathology of the AIDS dementia complex Ann Neurol 22 1987 700 706
96. W. Royal M. Updike O.A. Selnes HIV-1 infection and nervous system abnormalities among a cohort of intravenous drug users Neurology 41 1991 1905 1910
97. O.T. Rutschmann M. Opravil A. Iten A placebo controlled trial of didanosine plus stavudine with and without hydroxyurea for HIV infection AIDS 12 1998 F71 F77
98. N.C. Sacktor H. Bacellar D.R. Hoover Psychomotor slowing in HIV infection: A predictor of dementia, AIDS and death J Neurovirol 2 1996 404 410
99. N. Sacktor R.L. Skolasky R.H. Lyles Highly active antiretroviral therapy (HAART) improves cognitive impairment in HIV+ homosexual men J Neurovirol 4 1998 365
100. V.J. Sanders C.A. Pittman M.G. White Chemokines and receptors in HIV encephalitis AIDS 12 1998 1021 1026
101. P. Satz H. Morgenstern E.N. Miller Low education as a possible risk factor for cognitive abnormalities in HIV-1: Findings from the Multicenter AIDS Cohort Study J Acquir Immune Defic Syndr 6 1993 503 511
102. E. Schielke K. Tatsch H.W. Pfister Reduced cerebral blood flow in early stages of human immunodeficiency virus infection Arch Neurol 47 1990 1342 1345
103. J.J. Sidtis C. Gatsonis R.W. Price Zidovudine treatment of the AIDS dementia complex: Results of a placebo controlled trial Ann Neurol 33 1993 343 349
104. C.H. Silberstein F.P. McKegney M.A. O'Dowd A prospective longitudinal study of neuropsychological and psychosocial factors in asymptomatic individuals at risk of HTLV-III/LAV infection in a methadone program: Preliminary findings Int J Neurosci 32 1987 669 676
105. P. Simmonds Neurotropism of HIV type 1? AIDS Res Hum Retroviruses 12 1996 469 470
106. E. Sinclair F. Gray A. Giardi Immunohistochemical changes and PCR detection of HIV provirus DNA in brains of asymptomatic HIV positive patients J Neuropathol Exp Neurol 53 1994 43 50
107. J. Sweeney B.J. Brew J. Keilp Impairment of smooth pursuit in human immunodeficiency virus infection and its relationship to AIDS dementia complex J Psychiatry Neurosci 16 1991 247 252
108. K. Takahashi S.L. Wesselingh D.E. Griffin Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunohistochemistry Ann Neurol 39 1996 705 711
109. The Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders. A randomised double blind placebo controlled trial of deprenyland thioctic acid in human immunodeficiency virus associated cognitive impairment Neurology 50 1998 645 651
110. C. Tornatore R. Chandra J.R. Berger HIV-1 infection of subcortical astrocytes in the pediatric central nervous system Neurology 44 1994 481 487
111. V. Tozzi P. Narciso S. Galgani Effects of zidovudine in 30 patients with mild to end-stage AIDS dementia complex AIDS 7 1993 683 692
112. W. Tyor J.D. Glass J.W. Griffin Cytokine expression in the brain during the acquired immune deficiency syndrome Ann Neurol 31 1992 349 360
113. R. Vazeux C. Lacroix-Ciandie S. Blanche Low levels of human immunodeficiency virus replication in the brain tissue of children with severe acquired immunodeficiency syndrome encephalopathy Am J Pathol 140 1992 137 144
114. S.L. Wesselingh C. Power J.D. Glass Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia Ann Neurol 33 1994 576 582
115. C.A. Wiley Polymerase chain reaction in situ hybridisation—opening a Pandora's box? Ann Neurol 39 1996 691 692
116. K.C. Williams W.F. Hickey Traffic of lymphocytes into the CNS during inflammation and HIV infection J Neuro AIDS 1 1996 31 56